IL1B and systemic-onset juvenile idiopathic arthritis: Second, we identified a canakinumab response signature in many patients with SJIA that was characterized by the rapid normalization of transcript levels for SJIA overexpressed genes, including those associated with IL-1 and IL-6 signaling pathways.